MAPK3 and polycystic ovary syndrome: Previous microarray analyses disclosed that the destruction of ERK-1/2 changes the structure of approximately 77% of LH-regulated genes and defective ERK kinase signaling that is secondary to a genetic problem contributes to both ovulatory dysfunction and metabolic problems in PCOS.